Extensive weight loss reduces glycan age by altering IgG N-glycosylation

[1]  D. Sinclair,et al.  Biomarkers of biological age as predictors of COVID-19 disease severity , 2020, Aging.

[2]  S. Vermeire,et al.  Genetic Variants of the MGAT5 Gene Are Functionally Implicated in the Modulation of T Cells Glycosylation and Plasma IgG Glycome Composition in Ulcerative Colitis , 2020, Clinical and translational gastroenterology.

[3]  G. Lauc,et al.  Intense Physical Exercise Induces an Anti-inflammatory Change in IgG N-Glycosylation Profile , 2019, Front. Physiol..

[4]  Anand Rohatgi,et al.  Supplementation with the Sialic Acid Precursor N-acetyl-D-Mannosamine Breaks the Link Between Obesity and Hypertension. , 2019, Circulation.

[5]  P. O’Brien.  Bariatric surgery and type 2 diabetes: a step closer to defining an optimal approach. , 2019, The lancet. Diabetes & endocrinology.

[6]  T. Spector,et al.  TwinsUK: The UK Adult Twin Registry Update , 2019, Twin Research and Human Genetics.

[7]  Mark M. Davis,et al.  A clinically meaningful metric of immune age derived from high-dimensional longitudinal monitoring , 2019, Nature Medicine.

[8]  C. Gieger,et al.  Global variability of the human IgG glycome , 2019, bioRxiv.

[9]  J. Hui,et al.  Increased central adiposity is associated with pro-inflammatory immunoglobulin G N-glycans. , 2019, Immunobiology.

[10]  G. Lauc,et al.  N-glycosylation patterns of plasma proteins and immunoglobulin G in chronic obstructive pulmonary disease , 2018, Journal of Translational Medicine.

[11]  I. Gudelj,et al.  Immunoglobulin G glycosylation in aging and diseases. , 2018, Cellular immunology.

[12]  G. Lauc,et al.  Comparison of 2-Aminobenzamide, Procainamide and RapiFluor-MS as Derivatizing Agents for High-Throughput HILIC-UPLC-FLR-MS N-glycan Analysis , 2018, Front. Chem..

[13]  C. Franceschi,et al.  Inflammaging: a new immune–metabolic viewpoint for age-related diseases , 2018, Nature Reviews Endocrinology.

[14]  H. Wang,et al.  The association between subclass-specific IgG Fc N-glycosylation 1 profiles and hypertension in the Uygur , Kazak , Kirgiz and Tajik 2 populations 3 , 2019 .

[15]  S. Targan,et al.  Glycosylation of Immunoglobulin G Associates With Clinical Features of Inflammatory Bowel Diseases. , 2018, Gastroenterology.

[16]  T. Spector,et al.  Glycosylation Profile of Immunoglobulin G Is Cross-Sectionally Associated With Cardiovascular Disease Risk Score and Subclinical Atherosclerosis in Two Independent Cohorts , 2018, Circulation research.

[17]  Debabrata Ghosh,et al.  Hyposialylated IgG activates endothelial IgG receptor Fc&ggr;RIIB to promote obesity-induced insulin resistance , 2017, The Journal of clinical investigation.

[18]  F. Agakov,et al.  IgG glycan patterns are associated with type 2 diabetes in independent European populations. , 2017, Biochimica et biophysica acta. General subjects.

[19]  K. Clément,et al.  T Cell Populations and Functions Are Altered in Human Obesity and Type 2 Diabetes , 2017, Current Diabetes Reports.

[20]  N. Nguyen,et al.  Ten-year Outcomes of a Prospective Randomized Trial of Laparoscopic Gastric Bypass Versus Laparoscopic Gastric Banding , 2017, Annals of surgery.

[21]  Youxin Wang,et al.  Immunoglobulin G N-Glycans as Potential Postgenomic Biomarkers for Hypertension in the Kazakh Population. , 2017, Omics : a journal of integrative biology.

[22]  Igor Rudan,et al.  Mechanisms of disease: The human N-glycome. , 2016, Biochimica et biophysica acta.

[23]  I. Rudan,et al.  The Association Between Glycosylation of Immunoglobulin G and Hypertension , 2016, Medicine.

[24]  T. Takehara,et al.  Role of aberrant IgG glycosylation in the pathogenesis of inflammatory bowel disease , 2016, Proteomics. Clinical applications.

[25]  M. Lean,et al.  A clinical perspective of obesity, metabolic syndrome and cardiovascular disease , 2016, JRSM cardiovascular disease.

[26]  M. Wuhrer,et al.  Human plasma protein N-glycosylation , 2015, Glycoconjugate Journal.

[27]  C. Mineo,et al.  IgG Receptor Fc&ggr;RIIB Plays a Key Role in Obesity-Induced Hypertension , 2015, Hypertension.

[28]  D. Bates,et al.  Fitting Linear Mixed-Effects Models Using lme4 , 2014, 1406.5823.

[29]  I. Rudan,et al.  The association between galactosylation of immunoglobulin G and body mass index , 2014, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[30]  T. Spector,et al.  Glycans Are a Novel Biomarker of Chronological and Biological Ages , 2013, The journals of gerontology. Series A, Biological sciences and medical sciences.

[31]  G. Lauc,et al.  Alternative glycosylation modulates function of IgG and other proteins - implications on evolution and disease. , 2012, Biochimica et Biophysica Acta.

[32]  Andrew E. Jaffe,et al.  Bioinformatics Applications Note Gene Expression the Sva Package for Removing Batch Effects and Other Unwanted Variation in High-throughput Experiments , 2022 .

[33]  Pauline M. Rudd,et al.  High Throughput Isolation and Glycosylation Analysis of IgG–Variability and Heritability of the IgG Glycome in Three Isolated Human Populations* , 2011, Molecular & Cellular Proteomics.

[34]  J. Houwing-Duistermaat,et al.  Decreased Levels of Bisecting GlcNAc Glycoforms of IgG Are Associated with Human Longevity , 2010, PloS one.

[35]  S. Iida,et al.  Two mechanisms of the enhanced antibody-dependent cellular cytotoxicity (ADCC) efficacy of non-fucosylated therapeutic antibodies in human blood , 2009, BMC Cancer.

[36]  J. Ravetch,et al.  Anti-Inflammatory Activity of Immunoglobulin G Resulting from Fc Sialylation , 2006, Science.

[37]  F. dall’Olio.  Glycobiology of Aging. , 2018, Sub-cellular biochemistry.

[38]  R Core Team,et al.  R: A language and environment for statistical computing. , 2014 .